Comparison of the efficacy of accelerated corneal cross-linking therapy in different pediatric age groups having progressive keratoconus

ConclusionEven if proper treatment is applied, the progression of keratoconus is likely in patients younger than 14 years of age. Instead of evaluating pediatric patients as a whole, closer follow-up and early treatment may be useful in younger age groups ( ≤ 14 years).
Source: International Ophthalmology - Category: Opthalmology Source Type: research